Endocannabinoids as regulators of transient receptor potential (TRP) channels: A further opportunity to develop new endocannabinoid-based therapeutic drugs

Current Medicinal Chemistry

Volumn 17, Issue 14, 2010, Pages 1430-1449

  Di Marzo, V ^a   De Petrocellis, L ^b  

^a Institute of Biomolecular Chemistry   (Italy)

^b Endocannabinoid Research Group   (Italy)

Author keywords

Endocannabinoids; TRPA1; TRPM8; TRPV1

Indexed keywords

1,4 DIHYDROPYRIDINE DERIVATIVE; 4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ANANDAMIDE; ARVANIL; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CAPSAICIN; CAPSAICIN DERIVATIVE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN DEPENDENT KINASE 5; DESFLURANE; ENDOCANNABINOID; ENFLURANE; ISOFLURANE; N ARACHIDONOYLDOPAMINE; PIPERINE; PROTEIN KINASE C; PUTRESCINE; RESINIFERATOXIN; SEVOFLURANE; SPERMIDINE; SPERMINE; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANILLOID RECEPTOR 1; VENOM;

CHANNEL GATING; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SCREENING; HUMAN; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ARACHIDONIC ACIDS; ENDOCANNABINOIDS; HUMANS; PAIN; POLYUNSATURATED ALKAMIDES; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

EID: 77950660113     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710790980078     Document Type: Review

References (212)

1. Nilius, B.; Voets, T. TRP channels: a TR(I)P through a world of multifunctional cation channels. Pflugers Arch., 2005, 451, 1.
2. Vriens, J.; Owsianik, G.; Voets, T.; Droogmans, G.; Nilius, B. Invertebrate TRP proteins as functional models for mammalian channels. Pflugers Arch., 2004, 449, 213.
3. Owsianik, G.; D'hoedt, D.; Voets, T.; Nilius, B. Structure-function relationship of the TRP channel superfamily. Rev. Physiol. Biochem. Pharmacol., 2006, 156, 61.
4. Venkatachalam, K.; Montell, C. TRP channels. Annu. Rev. Biochem., 2007, 76, 387.
5. Nilius, B.; Owsianik, G.; Voets, T.; Peters, J.A. Transient receptor potential cation channels in disease. Physiol. Rev., 2007, 87, 165.
6. Caterina, M.J.; Schumacher, M.A.; Tominaga, M.; Rosen, T.A.; Levine, J.D.; Julius, D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature, 1997, 389, 816.
7. Tominaga, M.; Caterina, M.J.; Malmberg, A.B.; Rosen, T.A.; Gilbert, H.; Skinner, K.; Raumann, B.E.; Basbaum, A.I.; Julius, D. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron, 1998, 21, 531.
8. Holzer, P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience, 1988, 24, 739.
9. Caterina, M.J.; Leffler, A.; Malmberg, A.B.; Martin, W.J.; Trafton, J.; Petersen-Zeitz, K.R.; Koltzenburg, M.; Basbaum, A.I.; Julius, D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science, 2000, 288, 306. (Pubitemid 30226186)
10. Davis, J.B.; Gray, J.; Gunthorpe, M.J.; Hatcher, J.P.; Davey, P.T.; Overend, P.; Harries, M.H.; Latcham, J.; Clapham, C.; Atkinson, K.; Hughes, S.A.; Rance, K.; Grau, E.; Harper, A.J.; Pugh, P.L.; Rogers, D.C.; Bingham, S.; Randall, A.; Sheardown, S.A. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature, 2000, 405, 183.
11. Rashid, M.H.; Inoue, M.; Kondo, S.; Kawashima, T.; Bakoshi, S.; Ueda, H. Novel expression of vanilloid receptor 1 on capsaicinin-sensitive fibers accounts for the analgesic effect of capsaicin cream in neuropathic pain. J. Pharmacol. Exp. Ther., 2003, 304, 940. (Pubitemid 36254404)
12. Rashid, M.H.; Inoue, M.; Bakoshi, S.; Ueda, H. Increased expression of vanilloid receptor 1 on myelinated primary afferent neurons contributes to the antihyperalgesic effect of capsaicin cream in diabetic neuropathic pain in mice. J. Pharmacol. Exp. Ther., 2003, 306, 709. (Pubitemid 36886172)
13. Starowicz, K.; Cristino, L.; Di Marzo, V. TRPV1 receptors in the central nervous system: potential for previously unforeseen therapeutic applications. Curr. Pharm. Des., 2008, 14, 42.
14. Ahluwalia, J.; Urban, L.; Bevan, S.; Nagy, I. Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro. Eur. J. Neurosci., 2003, 17, 2611. (Pubitemid 36819286)
15. Price, T.J.; Patwardhan, A.; Akopian, A.N.; Hargreaves, K.M.; Flores, C.M. Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide. Br. J. Pharmacol., 2004, 141, 1118.
16. Cristino, L.; de Petrocellis, L.; Pryce, G.; Baker, D.; Guglielmotti, V.; Di Marzo, V. Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience, 2006, 139, 1405.
17. Anand, U.; Otto, W.R.; Sanchez-Herrera, D.; Facer, P.; Yiangou, Y.; Korchev, Y.; Birch, R.; Benham, C.; Bountra, C.; Chessell, I.P.; Anand, P. Cannabinoid receptor CB2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons. Pain, 2008, 138, 667.
18. Rossi, F.; Siniscalco, D.; Luongo, L.; De Petrocellis, L.; Bellini, G.; Petrosino, S.; Torella, M.; Santoro, C.; Nobili, B.; Perrotta, S.; Di Marzo, V.; Maione, S. The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption. Bone, 2009, 44, 476.
19. Di Marzo, V.; Cristino, L. Why endocannabinoids are not all alike. Nat. Neurosci., 2008, 11, 124.
20. 2+ signalling. Cell Calcium, 2009, 45, 611.
21. Hermann, H.; De Petrocellis, L.; Bisogno, T.; Schiano Moriello, A.; Lutz, B.; Di Marzo, V. Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response. Cell. Mol. Life Sci., 2003, 60, 607.
22. Fioravanti, B.; De Felice, M.; Stucky, C.L.; Medler, K.A.; Luo, M.C.; Gardell, L.R.; Ibrahim, M.; Malan, T.P. Jr; Yamamura, H.I.; Ossipov, M.H.; King, T.; Lai, J.; Porreca, F.; Vanderah, T.W. Constitutive activity at the cannabinoid CB1 receptor is required for behavioral response to noxious chemical stimulation of TRPV1: antinociceptive actions of CB1 inverse agonists. J. Neurosci., 2008, 28, 11593.
23. 2+ by vanilloid receptor I in rat dorsal root ganglion neurons. J. Biol. Chem., 2003, 278, 5462.
24. Turner, H.; Fleig, A.; Stokes, A.; Kinet, J.P.; Penner, R. Discrimination of intracellular calcium store subcompartments using TRPV1 (transient receptor potential channel, vanilloid subfamily member 1) release channel activity. Biochem. J., 2003, 371, 341.
25. 2+ entry. Biochem. J., 2003, 372, 517.
26. Xin, H.; Tanaka, H.; Yamaguchi, M.; Takemori, S.; Nakamura, A.; Kohama, K. Vanilloid receptor expressed in the sarcoplasmic reticulum of rat skeletal muscle. Biochem. Biophys. Res. Commun., 2005, 332, 756.
27. Gallego-Sandin, S.; Rodriguez-Garcia, A.; Alonso, M.T.; Garcia-Sancho, J. The endoplasmic reticulum of dorsal root ganglion neurons contains functional TRPV1 channels. J. Biol. Chem. 2009, 284, 32591
28. Vennekens, R.; Owsianik, G.; Nilius, B. Vanilloid transient receptor potential cation channels: an overview. Curr. Pharm. Des., 2008, 14, 18.
29. Appendino, G.; Minassi, A.; Pagani, A.; Ech-Chahad, A. The role of natural products in the ligand deorphanization of TRP channels. Curr. Pharm. Des., 2008, 14, 2.
30. Geppetti, P.; Holzer, P. Neurogenic Inflammation. CRC: Boca Raton, 1996.
31. Vriens, J.; Appendino, G.; Nilius, B. Pharmacology of vanilloid transient receptor potential cation channels. Mol. Pharmacol., 2009, 75, 1262.
32. Morita, A.; Iwasaki,Y.; Kobata, K.; Iida, T.; Higashi, T.; Oda, K.; Suzuki, A.; Narukawa, M.; Sasakuma, S.; Yokogoshi, H.; Yazawa, S.; Tominaga, M.; Watanabe, T. Lipophilicity of capsaicinoids and capsinoids influences the multiple activation process of rat TRPV1. Life Sci., 2006, 79, 2303.
33. Appendino, G.; Minassi, A.; Schiano Moriello, A.; De Petrocellis, L.; Di Marzo, V. N-Acylvanillamides: development of an expeditious synthesis and discovery of new acyl templates for powerful activation of the vanilloid receptor. J. Med. Chem., 2002, 45, 3739.
34. Appendino, G.; De Petrocellis, L.; Trevisani, M.; Minassi, A.; Daddario, N.; Schiano Moriello, A.; Gazzieri, D.; Ligresti, A.; Campi, B.; Fontana, G.; Pinna, C.; Geppetti, P.; Di Marzo, V. Development of the first ultra-potent "capsaicinoid" agonist at transient receptor potential vanilloid type 1 (TRPV1) channels and its therapeutic potential. J. Pharmacol. Exp. Ther., 2005, 312, 561.
35. Melck, D.; Bisogno, T.; De Petrocellis, L.; Chuang, H.; Julius, D.; Bifulco, M.; Di Marzo, V. Unsaturated long-chain N-acyl-vanillylamides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors. Biochem. Biophys. Res. Commun., 1999, 262, 275.
36. Di Marzo, V.; Bisogno, T.; De Petrocellis, L.; Brandi, I.; Jefferson, R.G.; Winckler, R.L.; Davis, J.B.; Dasse, O.; Mahadevan, A.; Razdan, R.K.; Martin, B.R. Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands. Biochem. Biophys. Res. Commun., 2001, 281, 444.
37. Di Marzo, V.; Griffin, G.; De Petrocellis, L.; Brandi, I.; Bisogno, T.; Williams, W.; Grier, M.C.; Kulasegram, S.; Mahadevan, A.; Razdan, R.K.; Martin, B.R. A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid. J. Pharmacol. Exp. Ther., 2002, 300, 984.
38. Szallasi, A; Szolcsanyi, J; Szallasi, Z; Blumberg, PM. Inhibition of [3H]resiniferatoxin binding to rat dorsal root ganglion membranes as a novel approach in evaluating compounds with capsaicin-like activity. Naunyn Schmiedebergs Arch. Pharmacol., 1991, 344, 551.
39. Liu, L.; Simon, S.A. Similarities and differences in the currents activated by capsaicin, piperine, and zingerone in rat trigeminal ganglion cells. J. Neurophysiol., 1996, 76, 1858.
40. McNamara, F.N.; Randall, A.; Gunthorpe, M.J. Effects of piperine, the pungent component of black pepper, at the human vanilloid receptor (TRPV1). Br. J. Pharmacol., 2005, 144, 781.
41. Xu, H.; Blair, N.T.; Clapham, D.E. Camphor activates and strongly desensitizes the transient receptor potential vanilloid subtype 1 channel in a vanilloid-independent mechanism. J. Neurosci., 2005, 25, 8924.
42. Yang, B.H.; Piao, Z.G.; Kim, Y.B.; Lee, C.H.; Lee, J.K.; Park, K.; Kim, J.S.; Oh, S.B. Activation of vanilloid receptor 1 (VR1) by eugenol. J. Dent. Res., 2003, 82, 781.
43. Dedov, V.N.; Tran, V.H.; Duke, C.C.; Connor, M.; Christie, M.J.; Mandadi, S.; Roufogalis, B.D. Gingerols: a novel class of vanilloid receptor (VR1) agonists. Br. J. Pharmacol., 2002, 137, 793.
44. Szallasi, A.; Blumberg, P.M. Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper. Neuroscience, 1989, 30, 515.
45. Appendino, G; Ech-Chahad, A; Minassi, A; Bacchiega, S; De Petrocellis, L; Di Marzo, V. Structure-activity relationships of the ultrapotent vanilloid resiniferatoxin (RTX): the homovanillyl moiety. Bioorg. Med. Chem. Lett. 2007, 17, 132.
46. Ahern, G.P.; Wang, X.; Miyares, R.L. Polyamines are potent ligands for the capsaicin receptor TRPV1. J. Biol. Chem., 2006, 281, 8991.
47. Cuypers, E.; Yanagihara, A.; Karlsson, E.; Tytgat, J. Jellyfish and other cnidarian envenomations cause pain by affecting TRPV1 channels. FEBS Lett., 2006, 580, 5728.
48. Siemens, J.; Zhou, S.; Piskorowski, R.; Nikai, T.; Lumpkin, E.A.; Basbaum, A.I.; King, D.; Julius, D. Spider toxins activate the capsaicin receptor to produce inflammatory pain. Nature, 2006, 444, 208.
49. Roh, E.J.; Keller, J.M.; Olah, .Z; Iadarola, M.J.; Jacobson, K.A. Structure-activity relationships of 1,4-dihydropyridines that act as enhancers of the vanilloid receptor 1 (TRPV1). Bioorg. Med. Chem., 2008, 16, 9349.
50. Cornett, P.M.; Matta, J.A.; Ahern, G.P. General anesthetics sensitize the capsaicin receptor transient receptor potential V1. Mol. Pharmacol., 2008, 74, 1261.
51. Marincsák, R.; Tóth, B.I.; Czifra, G.; Szabó, T.; Kovács, L.; Bíró, T. The analgesic drug, tramadol, acts as an agonist of the transient receptor potential vanilloid-1. Anesth. Analg., 2008, 106, 1890.
52. Cesare, P.; Dekker, L.V.; Sardini, A.; Parker, P.J.; McNaughton, P.A. Specific involvement of PKC-epsilon in sensitization of the neuronal response to painful heat. Neuron, 1999, 23, 617.
53. Chuang, H.H.; Prescott, E.D.; Kong, H.; Shields, S.; Jordt, S.E.; Basbaum, A.I.; Chao, M.V.; Julius, D. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature, 2001, 411, 957.
54. Tominaga, M.; Wada, M.; Masu, M. Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc. Natl. Acad. Sci. USA, 2001, 98, 6951.
55. Negri, L.; Lattanzi, R.; Giannini, E.; Colucci, M.; Margheriti, F.; Melchiorri, P.; Vellani, V.; Tian, H.; De Felice, M.; Porreca, F. Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: focus on interaction between PKR1 and the capsaicin receptor TRPV1 in pain behavior. J. Neurosci., 2006, 26, 6716.
56. Mohapatra, D.P.; Nau, C. Desensitization of capsaicin-activated currents in the vanilloid receptor TRPV1 is decreased by the cyclic AMP-dependent protein kinase pathway. J. Biol. Chem., 2003, 278, 50080.
57. Vellani, V.; Mapplebeck, S.; Moriondo, A.; Davis, J.B.; McNaughton, P.A. Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide. J. Physiol., 2001, 534, 813.
58. De Petrocellis, L.; Harrison, S.; Bisogno, T.; Tognetto, M.; Brandi, I.; Smith, G.D.; Creminon, C.; Davis, J.B.; Geppetti, P.; Di Marzo, V. The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase. J. Neurochem., 2001, 77, 1660.
59. Sculptoreanu, A.; de Groat, W.C.; Buffington, C.A.; Birder, L.A. Protein kinase C contributes to abnormal capsaicin responses in DRG neurons from cats with feline interstitial cystitis. Neurosci. Lett., 2005, 381, 42.
60. Wang, Y.; Toth, A.; Tran, R.; Szabo, T.; Welter, J.D.; Blumberg, P.M.; Lee, J.; Kang, S.U.; Lim, J.O.; Lee, J. High-affinity partial agonists of the vanilloid receptor. Mol. Pharmacol., 2003, 64, 325.
61. Premkumar, L.S.; Ahern, G.P. Induction of vanilloid receptor channel activity by protein kinase C. Nature, 2000, 408, 985.
62. Cesare, P.; McNaughton, P. A novel heat-activated current in nociceptive neurons and its sensitization by bradykinin. Proc. Natl. Acad. Sci. USA, 1996, 93, 15435.
63. Moriyama, T.; Iida, T.; Kobayashi, K.; Higashi, T.; Fukuoka, T.; Tsumura, H.; Leon, C.; Suzuki, N.; Inoue, K.; Gachet, C.; Noguchi, K.; Tominaga, M. Possible involvement of P2Y2 metabotropic receptors in ATP-induced transient receptor potential vanilloid receptor 1-mediated thermal hypersensitivity. J. Neurosci., 2003, 23, 6058.
64. Sugiura, T.; Tominaga, M.; Katsuya, H.; Mizumura, K. Bradykinin lowers the threshold temperature for heat activation of vanilloid receptor 1. J. Neurophysiol., 2002, 88, 544.
65. Numazaki, M.; Tominaga, T.; Toyooka, H.; Tominaga, M. Direct phosphorylation of capsaicin receptor VR1 by protein kinase Cepsilon and identification of two target serine residues. J. Biol. Chem., 2002, 277, 13375.
66. Bhave, G.; Hu, H.J.; Glauner, K.S.; Zhu, W.; Wang, H.; Brasier, D.J.; Oxford, G.S.; Gereau, R.W. 4th. Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1). Proc. Natl. Acad. Sci. USA, 2003, 100, 12480.
67. Bhave, G.; Zhu, W.; Wang, H.; Brasier, D.J.; Oxford, G.S.; Gereau, R.W. 4th. cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Neuron, 2002, 35, 721.
68. Vetter, I.; Wyse, B.D.; Monteith, G.R.; Roberts-Thomson, S.J.; Cabot, P. The mu opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathway. J. Mol. Pain, 2006, 2, 22.
69. 2+/calmodulin-dependent kinase II regulates its vanilloid binding. J. Biol. Chem., 2004, 279, 7048.
70. Jin, X.; Morsy, N.; Winston, J.; Pasricha, P.J.; Garrett, K.; Akbarali, H.I. Modulation of TRPV1 by nonreceptor tyrosine kinase, c-Src kinase. Am. J. Physiol. Cell Physiol., 2004, 287, C558.
71. Zhang, X.; Huang, J.; McNaughton, P.A. NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels. EMBO J., 2005, 24, 4211.
72. Stein, A.T.; Ufret-Vincenty, C.A.; Hua, L.; Santana, L.F.; Gordon, S.E. Phosphoinositide 3-kinase binds to TRPV1 and mediates NGF-stimulated TRPV1 trafficking to the plasma membrane. J. Gen. Physiol., 2006, 128, 509.
73. Ji, R.R.; Samad, T.A.; Jin, S.X.; Schmoll, R.; Woolf, C.J. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron, 2002, 36, 57.
74. Bron, R.; Klesse, L.J.; Shah, K.; Parada, L.F.; Winter, J. Activation of Ras is necessary and sufficient for upregulation of vanilloid receptor type 1 in sensory neurons by neurotrophic factors. Mol. Cell. Neurosci., 2003, 22, 118.
75. Anand, U.; Otto, W.R.; Casula, M.A.; Day, N.C.; Davis, J.B.; Bountra, C.; Birch, R.; Anand, P. The effect of neurotrophic factors on morphology, TRPV1 expression and capsaicin responses of cultured human DRG sensory neurons. Neurosci. Lett., 2006, 399, 51.
76. Pareek, T.K.; Keller, J.; Kesavapany, S.; Pant, H.C.; Iadarola, M.J.; Brady, R.O.; Kulkarni, A.B. Cyclin-dependent kinase 5 activity regulates pain signaling. Proc. Natl. Acad. Sci. USA, 2006, 103, 791.
77. Pareek, T.K.; Kulkarni, A.B. Cdk5: a new player in pain signaling. Cell Cycle, 2006, 5, 585.
78. Pareek, T.K.; Keller, J.; Kesavapany, S.; Agarwal, N.; Kuner, R.; Pant, H.C.; Iadarola, M.J.; Brady, R.O.; Kulkarni, A.B. Cyclin-dependent kinase 5 modulates nociceptive signaling through direct phosphorylation of transient receptor potential vanilloid 1. Proc. Natl. Acad. Sci. USA, 2007, 104, 660.
79. Moriyama, T.; Higashi, T.; Togashi, K.; Iida, T.; Segi, E.; Sugimoto, Y.; Tominaga, T.; Narumiya, S.; Tominaga, M. Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins. Mol. Pain, 2005, 1, 3.
80. Ohta, T.; Ikemi, Y.; Murakami, M.; Imagawa, T.; Otsuguro, K.; Ito, S. Potentiation of transient receptor potential V1 functions by the activation of metabotropic 5-HT receptors in rat primary sensory neurons. J. Physiol., 2006, 576, 809.
81. Amadesi, S.; Nie, J.; Vergnolle, N.; Cottrell, G.S.; Grady, E.F.; Trevisani, M.; Manni, C.; Geppetti, P.; McRoberts, J.A.; Ennes, H.; Davis, J.B.; Mayer, E.A.; Bunnett, N.W. Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J. Neurosci., 2004, 24, 4300.
82. Amadesi, S.; Cottrell, G.S.; Divino, L.; Chapman, K.; Grady, E.F.; Bautista, F.; Karanjia, R.; Barajas-Lopez, C.; Vanner, S.; Vergnolle, N.; Bunnett, N.W. Protease-activated receptor 2 sensitizes TRPV1 by protein kinase Cepsilon- and A-dependent mechanisms in rats and mice. J. Physiol., 2006, 575, 555.
83. Zhang, X.; Li, L.; McNaughton, P.A. Proinflammatory mediators modulate the heat-activated ion channel TRPV1 via the scaffolding protein AKAP79/150. Neuron, 2008, 59, 450.
84. Prescott, E.D.; Julius, D. A modular PIP2 binding site as a determinant of capsaicin receptor sensitivity. Science, 2003, 300, 1284.
85. Nilius, B.; Owsianik, G.; Voets, T. Transient receptor potential channels meet phosphoinositides. EMBO J., 2008, 27, 2809.
86. Lauckner, J.E.; Hille, B.; Mackie, K. The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins. Proc. Natl. Acad. Sci. USA, 2005, 102, 19144.
87. De Petrocellis, L.; Marini, P.; Matias, I.; Schiano Moriello, A.; Starowicz, K.; Cristino, L.; Nigam, .S; Di Marzo, V. Mechanisms for the coupling of cannabinoid receptors to intracellular calcium mobilization in rat insulinoma beta-cells. Exp. Cell Res., 2007, 313, 2993.
88. Marini, P.; Schiano Moriello, A.; Cristino, L.; Palmery, M.; De Petrocellis, L.; Di Marzo, V. Cannabinoid CB1 receptor elevation of intracellular calcium in neuroblastoma SH-SY5Y cells: interactions with muscarinic and delta-opioid receptors. Biochim. Biophys. Acta, 2009, 1793, 1289.
89. 2+ influx via TRPV1 channels. EMBO J., 2005, 24, 3026.
90. Malcher-Lopes, R.; Di, S.; Marcheselli, V.S.; Weng, F.J.; Stuart, C.T.; Bazan, N.G.; Tasker, J.G. Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release. J. Neurosci., 2006, 26, 6643.
91. Vellani, V.; Petrosino, S.; De Petrocellis, L.; Valenti, M.; Prandini, M.; Magherini, P.C.; McNaughton, P.A.; Di Marzo, V. Functional lipidomics. Calcium-independent activation of endocannabinoid/endovanilloid lipid signalling in sensory neurons by protein kinases C and A and thrombin. Neuropharmacology, 2008, 55, 1274.
92. Shin, J.; Cho, H.; Hwang, S.W.; Jung, J.; Shin, C.Y.; Lee, S.Y.; Kim, S.H.; Lee, M.G.; Choi, Y.H.; Kim, J.; Haber, N.A.; Reichling, D.B.; Khasar, S.; Levine, J.D.; Oh, U. Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc. Natl. Acad. Sci. USA, 2002, 99, 10150.
93. Hwang, S.W.; Cho, H.; Kwak, J.; Lee, S.Y.; Kang, C.J.; Jung, J.; Cho, S.; Min, K.H.; Suh, Y.G.; Kim, D.; Oh, U. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc. Natl. Acad. Sci. USA, 2000, 97, 6155.
94. van der Stelt, M.; Di Marzo, V. Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels. Eur. J. Biochem., 2004, 271, 1827.
95. Di Marzo, V.; Bisogno, T.; De Petrocellis, L. Anandamide: some like it hot. Trends Pharmacol. Sci. 2001, 22, 346.
96. Di Marzo, V.; Bisogno, T.; Melck, D.; Ross, R.; Brockie, H.; Stevenson, L.; Pertwee, R.; De Petrocellis, L. Interactions between synthetic vanilloids and the endogenous cannabinoid system. FEBS Lett., 1998, 436, 449.
97. Zygmunt, P.M.; Petersson, J.; Andersson, D.A.; Chuang, H.; Sørgård, M.; Di Marzo, V.; Julius, D.; Högestätt, E.D. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature, 1999, 400, 452.
98. Huang, S.M.; Bisogno, T.; Trevisani, M.; Al-Hayani, A.; De Petrocellis, L.; Fezza, F.; Tognetto, M.; Petros, T.J.; Krey, J.F.; Chu, C.J.; Miller, J.D.; Davies, S.N.; Geppetti, P.; Walker, J.M.; Di Marzo, V. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc. Natl. Acad. Sci. USA, 2002, 99, 8400.
99. Smart, D.; Gunthorpe, M.J.; Jerman, J.C.; Nasir, S.; Gray, J.; Muir, A.I.; Chambers, J.K.; Randall, A.D.; Davis, J.B. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br. J. Pharmacol., 2000, 129, 227.
100. Chu, C.J.; Huang, S.M.; De Petrocellis, L.; Bisogno, T.; Ewing, S.A.; Miller, J.D.; Zipkin, R.E.; Daddario, N.; Appendino, G.; Di Marzo, V.; Walker, J.M. N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia. J. Biol. Chem., 2003, 278, 13633.
101. Movahed, P.; Jönsson, B.A.; Birnir, B.; Wingstrand, J.A.; Jørgensen, T.D.; Ermund, A.; Sterner, O.; Zygmunt, P.M; Högestätt, E.D. Endogenous unsaturated C18 N-acylethanolamines are vanilloid receptor (TRPV1) agonists. J. Biol. Chem. 2005, 280, 38496.
102. De Petrocellis, L.; Chu, C.J.; Schiano Moriello, A.; Kellner, J.C.; Walker, J.M.; Di Marzo, V. Actions of two naturally occurring saturated N-acyldopamines on transient receptor potential vanilloid 1 (TRPV1) channels. Br. J. Pharmacol., 2004, 143, 251.
103. Patwardhan, A.M.; Scotland, P.E.; Akopian, A.N.; Hargreaves, K.M. Activation of TRPV1 in the spinal cord by oxidized linoleic acid metabolites contributes to inflammatory hyperalgesia. Proc. Natl. Acad. Sci. USA, 2009, 106,18820.
104. Woo, D.H.; Jung, S.J.; Zhu, M.H.; Park, C.K.; Kim, Y.H.; Oh, S.B.; Lee, C.J. Direct activation of transient receptor potential vanilloid 1(TRPV1) by diacylglycerol (DAG). Mol. Pain, 2008, 4, 42.
105. Jordt, S.E.; Julius, D. Molecular basis for species-specific sensitivity to "hot" chili peppers. Cell, 2002 108, 421.
106. Jung, J.; Hwang, S.W.; Kwak, J.; Lee, S.Y.; Kang, C.J.; Kim, W.B.; Kim, D.; Oh, U. Capsaicin binds to the intracellular domain of the capsaicin-activated ion channel. J. Neurosci., 1999, 19, 529. (Pubitemid 29036004)
107. De Petrocellis, L.; Bisogno, T.; Maccarrone, M.; Davis, J.B.; Finazzi-Agrò, A.; Di Marzo, V. The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J. Biol. Chem., 2001, 276, 12856. (Pubitemid 37385205)
108. Chou, M.Z.; Mtui, T.; Gao, Y.D.; Kohler, M.; Middleton, R.E. Resiniferatoxin binds to the capsaicin receptor (TRPV1) near the extracellular side of the S4 transmembrane domain. Biochemistry, 2004, 43, 2501.
109. Johnson, D.M.; Garrett, E.M.; Rutter, R.; Bonnert, T.P.; Gao, Y.D.; Middleton, R.E.; Sutton, K.G. Functional mapping of the transient receptor potential vanilloid 1 intracellular binding site. Mol. Pharmacol., 2006, 70, 1005.
110. Jung, J.; Lee, S.Y.; Hwang, S.W.; Cho, H.; Shin, J.; Kang, Y.S.; Kim, S.; Oh, U. Agonist recognition sites in the cytosolic tails of vanilloid receptor 1. J. Biol. Chem., 2002, 277, 44448. (Pubitemid 36157879)
111. Vlachová, V.; Teisinger, J.; Susánková, K.; Lyfenko, A.; Ettrich, R.; Vyklický, L. Functional role of C-terminal cytoplasmic tail of rat vanilloid receptor 1. J. Neurosci., 2003, 23, 1340. (Pubitemid 36258912)
112. Gavva, N.R.; Klionsky, L.; Qu, Y.; Shi, L.; Tamir, R.; Edenson, S.; Zhang, T.J.; Viswanadhan, V.N.; Toth, A.; Pearce, L.V.; Vanderah, T.W.; Porreca, F.; Blumberg, P.M.; Lile, J.; Sun, Y.; Wild, K.; Louis, J.C.; Treanor, J.J. Molecular determinants of vanilloid sensitivity in TRPV1. J. Biol. Chem., 2004, 279, 20283.
113. Janusz, J.M.; Buckwalter, B.L.; Young, P.A.; LaHann, T.R.; Farmer, R.W.; Kasting, G.B.; Loomans, M.E.; Kerkaert, G.A.; Maddin, C.S.; Berman, E.F.; Bohne, R.L.; Cupps, T.L.; Milstein, J.R. Vanilloids. 1. Analogs of capsaicin with antinociceptive and antiinflammatory activity. J. Med. Chem., 1993, 36, 2595.
114. Lazar, J.; Braun, D.C.; Tóth, A.; Wang, Y.; Pearce, L.V.; Pavlyukovets, V.A.; Blumberg, P.M.; Garfield, S.H.; Wincovitch, S.; Choi, H.K.; Lee, J. Kinetics of penetration influence the apparent potency of vanilloids on TRPV1. Mol. Pharmacol., 2006, 69, 1166.
115. Liu, L.; Lo, Y-C.; Chen, I-J.; Simon, S.A. The responses of rat trigeminal ganglion neurons to capsaicin and two nonpungent vanilloid receptor agonists, olvanil and glyceryl nonamide. J. Neurosci., 1997, 17, 4101.
116. Price, T.J.; Patwardhan, A.M.; Flores, C.M.; Hargreaves, K.M. A role for the anandamide membrane transporter in TRPV1-mediated neurosecretion from trigeminal sensory neurons. Neuropharmacology, 2005, 49, 25.
117. Di Marzo, V.; Bisogno, T.; De Petrocellis, L. Endocannabinoids and related compounds: walking back and forth between plant natural products and animal physiology. Chem. Biol., 2007, 14, 741.
118. Appendino, G.; Cascio, M.G.; Bacchiega, S.; Schiano Moriello, A.; Minassi, A.; Thomas, A.; Ross, R.; Pertwee, R.; De Petrocellis, L.; Di Marzo, V. First "hybrid" ligands of vanilloid TRPV1 and cannabinoid CB2 receptors and non-polyunsaturated fatty acid-derived CB2-selective ligands. FEBS Lett., 2006, 580, 568.
119. Abadji, V.; Lin, S.; Taha, G.; Griffin, G.; Stevenson, L.A.; Pertwee, R.G.; Makriyannis, A. (R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability. J. Med. Chem., 1994, 37, 1889.
120. Hillard, C.J.; Manna, S.; Greenberg, M.J.; DiCamelli, R.; Ross, R.A.; Stevenson, L.A.; Murphy, V.; Pertwee, R.G.; Campbell, W.B. Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). J. Pharmacol. Exp. Ther., 1999, 289, 1427.
121. Martin, B.R.; Mechoulam, R.; Razdan, R.K. Discovery and characterization of endogenous cannabinoids. Life Sci., 1999, 65, 573.
122. Ueda, Y.; Miyagawa, N.; Wakitani, K. Involvement of cannabinoid CB2 receptors in the IgE-mediated triphasic cutaneous reaction in mice. Life Sci., 2007, 80, 414. (Pubitemid 46013906)
123. Reggio, P.H. Endocannabinoid structure-activity relationships for interaction at the cannabinoid receptors. Prostaglandins Leukot. Essent. Fatty Acids, 2002, 66, 143.
124. Barnett-Norris, J.; Hurst D.P.; Lynch, D.L.; Guarnieri, F.; Makriyannis, A.; Reggio, P.H. Conformational memories and the endocannabinoid binding site at the cannabinoid CB1 receptor. J. Med. Chem., 2002, 45, 3649.
125. Appendino, G.; Minassi, A.; Berton, L, Schiano Moriello, A.; Cascio, M.G.; De Petrocellis, L.; Di Marzo, V. Oxyhomologues of anandamide and related endolipids: chemoselective synthesis and biological activity. J. Med. Chem. 2006, 49, 2333.
126. De Petrocellis, L.; Bisogno, T.; Davis, J.B.; Pertwee, R.G.; Di Marzo, V. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett., 2000, 483, 52.
127. De Petrocellis, L.; Deva, R.; Mainieri, F.; Schaefer, M.; Bisogno, T.; Ciccoli, R.; Ligresti, A.; Hill, K.; Nigam, S.; Appendino, G.; Di Marzo, V. Chemical synthesis, pharmacological characterization, and possible formation in unicellular fungi of 3-hydroxyanandamide. J. Lipid Res., 2009, 50, 658.
128. Matias, I.; Chen, J.; De Petrocellis, L. Bisogno, T.; Ligresti, A.; Fezza, F.; Krauss, A.H.; Shi, L.; Protzman.;C.E, Li.; C.; Liang, Y.; Nieves, A.L.; Kedzie, K.M.; Burk, R.M.; Di Marzo, V.; Woodward, D.F. Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism. J. Pharmacol. Exp. Ther., 2004, 309, 745.
129. Appendino, G.; Ligresti, A.; Minassi, A.; Cascio, M.G.; Allarà, M.; Taglialatela-Scafati, O.; Pertwee, R.G.; De Petrocellis, L.; Di Marzo, V. Conformationally constrained fatty acid ethanolamides as cannabinoid and vanilloid receptor probes. J. Med. Chem., 2009, 52, 3001.
130. Appendino, G.; Daddario, N.; Minassi, A.; Schiano Moriello, A.; De Petrocellis, L.; Di Marzo, V. The taming of capsaicin. Reversal of the vanilloid activity of N-acylvanillamines by aromatic iodination. J. Med. Chem., 2005, 48, 4663. (Pubitemid 40993425)
131. Appendino, G.; Bacchiega, S.; Minassi, A.; Cascio, M.G.; De Petrocellis, L.; Di Marzo, V. The 1,2,3-triazole ring as a peptido- and olefinomimetic element: discovery of click vanilloids and cannabinoids. Angew. Chem. Int. Ed., 2007, 46, 9312. (Pubitemid 350292167)
132. Dhaka, A.; Viswanath, V.; Patapoutian, A. Trp ion channels and temperature sensation. Annu. Rev. Neurosci., 2006, 29, 135. (Pubitemid 44476842)
133. Wilson-Gerwing, T.D.; Dmyterko, M.V.; Zochodne, D.W.; Johnston, J.M.; Verge, V.M. Neurotrophin-3 suppresses thermal hyperalgesia associated with neuropathic pain and attenuates transient receptor potential vanilloid receptor-1 expression in adult sensory neurons. J. Neurosci., 2005, 25, 758.
134. Szallasi, A.; Cortright, D.N.; Blum, C.A.; Eid, S.R. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat. Rev. Drug Discov., 2007, 6, 357.
135. Gavva, N.R.; Tamir, R.; Klionsky, L.; Norman, M.H.; Louis, J.C.; Wild, K.D.; Treanor, J.J. Proton activation does not alter antagonist interaction with the capsaicin-binding pocket of TRPV1. Mol. Pharmacol., 2005, 68, 1524.
136. Appendino, G.; Harrison, S.; De Petrocellis, L.; Daddario, N.; Bianchi, F.; Schiano Moriello, A.; Trevisani, M.; Benvenuti, F.; Geppetti, P.; Di Marzo, V. Halogenation of a capsaicin analogue leads to novel vanilloid TRPV1 receptor antagonists. Br. J. Pharmacol., 2003, 139, 1417. (Pubitemid 37174655)
137. Wahl, P.; Foged, C.; Tullin, S.; Thomsen, C. Iodo-resiniferatoxin, a new potent vanilloid receptor antagonist. Mol. Pharmacol., 2001, 59, 9.
138. Undem, B.J.; Kollarik, M. Characterization of the vanilloid receptor 1 antagonist iodo-resiniferatoxin on the afferent and efferent function of vagal sensory C-fibers. J. Pharmacol. Exp. Ther., 2002, 303, 716. (Pubitemid 35231246)
139. McDonnell, M.E.; Zhang, S.P.; Dubin, A.E.; Dax, S.L. Synthesis and in vitro evaluation of a novel iodinated resiniferatoxin derivative that is an agonist at the human vanilloid VR1 receptor. Bioorg. Med. Chem. Lett., 2002, 12, 1189.
140. Márquez, N.; De Petrocellis, L.; Caballero, F.J.; Macho, A., Schiano-Moriello, A.; Minassi, A.; Appendino, G.; Muñoz, E.; Di Marzo, V. Iodinated N-acylvanillamines: potential "multiple-target" anti-inflammatory agents acting via the inhibition of t-cell activation and antagonism at vanilloid TRPV1 channels. Mol. Pharmacol., 2006, 69, 1373.
141. Shimizu, I.; Iida, T.; Horiuchi, N.; Caterina, M.J. 5-Iodoresiniferatoxin evokes hypothermia in mice and is a partial transient receptor potential vanilloid 1 agonist in vitro. J. Pharmacol. Exp. Ther., 2005, 314, 1378.
142. Bisogno, T.; Melck, D.; De Petrocellis, L.; Bobrov, M.Yu.; Gretskaya, N.M.; Bezuglov, V.V.; Sitachitta, N.; Gerwick, W.H.; Di Marzo, V. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase. Biochem. Biophys. Res. Commun., 1998, 248, 515.
143. de Lago, E.; Petrosino, S.; Valenti, M.; Morera, E.; Ortega-Gutierrez, S.; Fernandez-Ruiz, J.; Di Marzo, V. Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels. Biochem. Pharmacol., 2005, 70, 446. (Pubitemid 40905116)
144. Maione, S.; De Petrocellis, L.; de Novellis, V.; Schiano Moriello, A.; Petrosino, S.; Palazzo, E; Rossi, F.S.; Woodward, D.F.; Di Marzo, V. Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors. Br. J. Pharmacol., 2007, 150, 766. (Pubitemid 46440215)
145. Ortar, G.; Cascio, M.G.; De Petrocellis, L.; Morera, E.; Rossi, F.; Schiano-Moriello, A.; Nalli, M.; de Novellis, V.; Woodward, D.F.; Maione, S.; Di Marzo, V. New N-arachidonoylserotonin analogues with potential "dual" mechanism of action against pain. J. Med. Chem., 2007, 50, 6554.
146. Valenzano, K.J.; Grant, E.R.; Wu, G.; Hachicha, M.; Schmid, L.; Tafesse, L.; Sun, Q.; Rotshteyn, Y.; Francis, J.; Limberis, J.; Malik, S.; Whittemore, E.R.; Hodges, D. N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl) tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I. in vitro characterization and pharmacokinetic properties. J. Pharmacol. Exp. Ther., 2003, 306, 377.
147. Pomonis, J.D.; Harrison, J.E.; Mark, L.; Bristol, D.R; Valenzano, K.J.; Walker, K. N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. in vivo characterization in rat models of inflammatory and neuropathic pain. J. Pharmacol. Exp. Ther., 2003, 306, 387.
148. Ahn, K.; Johnson, D.S.; Fitzgerald, L.R.; Liimatta, M.; Arendse, A.; Stevenson, T.; Lund, E.T.; Nugent, R.A.; Nomanbhoy, T.K.; Alexander, J.P.; Cravatt, B.F. Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity. Biochemistry, 2007, 46, 13019.
149. Morera, E.; De Petrocellis, L.; Morera, L.; Schiano Moriello, A.; Ligresti, A.; Di Marzo, V.; Ortar, G. Synthesis and biological evaluation of piperazinyl carbamates and ureas as fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channel dual ligands. Bioorg. Med. Chem. Lett., 2009, 19, 6806.
150. Kym, P.R.; Kort, M.E.; Hutchins, C.W. Analgesic potential of TRPV1 antagonists. Biochem. Pharmacol., 2009, 78, 211.
151. Steiner, A.A.; Turek, V.F.; Almeida, M.C.; Burmeister, J.J.; Oliveira, D.L.; Roberts, J.L.; Bannon, A.W.; Norman, M.H.; Louis, J.C.; Treanor, J.J.; Gavva, N.R.; Romanovsky, A.A. Nonthermal activation of transient receptor potential vanilloid-1 channels in abdominal viscera tonically inhibits autonomic cold-defense effectors. J. Neurosci., 2007, 27, 7459.
152. Lehto, S.G.; Tamir, R.; Deng, H.; Klionsky, L.; Kuang, R.; Le, A.; Lee, D.; Louis, J.C.; Magal, E.; Manning, B.H.; Rubino, J.; Surapaneni, S.; Tamayo, N.; Wang, T.; Wang, J.; Wang, J.; Wang, W.; Youngblood, B.; Zhang, M.; Zhu, D.; Norman, M.H.; Gavva, N.R. Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3- dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl) -acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats. J. Pharmacol. Exp. Ther., 2008, 326, 218.
153. Gavva, N.R. Body-temperature maintenance as the predominant function of the vanilloid receptor TRPV1. Trends Pharmacol. Sci., 2008, 29, 550.
154. Story, G.M.; Peier, A.M.; Reeve, A.J.; Eid, S.R.; Mosbacher, J.; Hricik, T.R.; Earley, T.J.; Hergarden, A.C.; Andersson, D.A.; Hwang, S.W.; McIntyre, P.; Jegla, T.; Bevan, S.; Patapoutian, A. ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell, 2003, 112, 819.
155. Jordt, S.E.; Bautista, D.M.; Chuang, H.H.; McKemy, D.D.; Zygmunt, P.M.; Högestätt, E.D.; Meng, I.D.; Julius, D. Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature, 2004, 427, 260. (Pubitemid 38112043)
156. Obata, K.; Katsura, H. Mizushima, T.; Yamanaka, H.; Kobayashi, K.; Dai, Y.; Fukuoka, T.; Tokunaga, A.; Tominaga, M.; Noguchi, K. TRPA1 induced in sensory neurons contributes to cold hyperalgesia after inflammation and nerve injury. J. Clin. Invest., 2005, 115, 2393. (Pubitemid 41266201)
157. Katsura, H.; Obata, K.; Mizushima, T.; Yamanaka, H.; Kobayashi, K.; Dai, Y.; Fukuoka, T.; Tokunaga, A.; Sakagami, M.; Noguchi, K. Antisense knock down of TRPA1, but not TRPM8, alleviates cold hyperalgesia after spinal nerve ligation in rats. Exp. Neurol., 2006, 200, 112. (Pubitemid 44080752)
158. Karashima, Y.; Talavera, K.; Everaerts, W.; Janssens, A.; Kwan, K.Y.; Vennekens, R.; Nilius, B.; Voets, T. TRPA1 acts as a cold sensor in vitro and in vivo. Proc. Natl. Acad. Sci. USA, 2009, 106, 1273.
159. Bandell, M.; Story, G.M.; Hwang, S.W.; Viswanath, V.; Eid, S.R.; Petrus, M.J.; Earley, T.J.; Patapoutian, A. Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron, 2004, 41, 849. (Pubitemid 38429729)
160. McKemy, D.D. How cold is it? TRPM8 and TRPA1 in the molecular logic of cold sensation. Mol. Pain, 2005, 1, 16.
161. Kobayashi, K.; Fukuoka, T.; Obata, K.; Yamanaka, H.; Dai, Y.; Tokunaga, A.; Noguchi, K. Distinct expression of TRPM8, TRPA1, and TRPV1 mRNAs in rat primary afferent neurons with adelta/c-fibers and colocalization with trk receptors. J. Comp. Neurol., 2005, 493, 596. (Pubitemid 41780630)
162. Bautista, D.M.; Movahed, P.; Hinman, A.; Axelsson, H.E.; Sterner, O.; Högestätt, E.D.; Julius, D.; Jordt, S.E.; Zygmunt, P.M. Pungent products from garlic activate the sensory ion channel TRPA1. Proc. Natl. Acad. Sci. USA, 2005, 102, 12248. (Pubitemid 41291160)
163. Diogenes, A.; Akopian, A.N.; Hargreaves, K.M. NGF up-regulates TRPA1: implications for orofacial pain. J. Dent. Res., 2007, 86, 550.
164. Tominaga, M.; Caterina, M.J. Thermosensation and pain. J. Neurobiol., 2004, 61, 3.
165. Corey, D.P.; García-Añoveros, J.; Holt, J.R.; Kwan, K.Y.; Lin, S.Y.; Vollrath, M.A.; Amalfitano, A.; Cheung, E.L.; Derfler, B.H.; Duggan, A.; Géléoc, G.S.; Gray, P.A.; Hoffman, M.P.; Rehm, H.L.; Tamasauskas, D.; Zhang, D.S. TRPA1 is a candidate for the mechanosensitive transduction channel of vertebrate hair cells. Nature, 2004, 432, 723. (Pubitemid 39656287)
166. Bautista, D.M.; Jordt, S.E.; Nikai, T.; Tsuruda, P.R.; Read, A.J.; Poblete, J.; Yamoah, E.N.; Basbaum, A.I.; Julius, D. TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell, 2006, 124, 1269.
167. Kwan, K.Y.; Allchorne, A.J.; Vollrath, M.A.; Christensen, A.P.; Zhang, D.S.; Woolf, C.J.; Corey, D.P. TRPA1 contributes to cold, mechanical, and chemical nociception but is not essential for hair-cell transduction. Neuron, 2006, 50, 277.
168. Macpherson, L.J.; Geierstanger, B.H.; Viswanath, V.; Bandell, M.; Eid, S.R.; Hwang, S.; Patapoutian, A. The pungency of garlic: activation of TRPA1 and TRPV1 in response to allicin. Curr. Biol., 2005, 15, 929. (Pubitemid 40772062)
169. Macpherson, L.J.; Dubin, A.E.; Evans, M.J.; Marr, F.; Schultz, P.G.; Cravatt, B.F.; Patapoutian, A. Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines. Nature, 2007, 445, 541. (Pubitemid 46197634)
170. Xu, H.; Delling, M.; Jun, J.C.; Clapham, D.E. Oregano, thyme and clove-derived flavors and skin sensitizers activate specific TRP channels. Nat. Neurosci., 2006, 9, 628.
171. Namer, B; Seifert, F; Handwerker, HO; Maihöfner, C. TRPA1 and TRPM8 activation in humans: effects of cinnamaldehyde and menthol. Neuroreport, 2005, 16, 955.
172. McNamara, C.R.; Mandel-Brehm, J.; Bautista, D.M.; Siemens, J.; Deranian, K.L.; Zhao, M.; Hayward, N.J.; Chong, J.A.; Julius, D.; Moran, M.M.; Fanger, C.M. TRPA1 mediates formalin-induced pain. Proc. Natl. Acad. Sci. USA, 2007, 104, 13525.
173. Talavera, K.; Gees, M.; Karashima, Y.; Meseguer, V.M.; Vanoirbeek, J.A.; Damann, N.; Everaerts, W.; Benoit, M.; Janssens, A.; Vennekens, R.; Viana, F.; Nemery, B.; Nilius, B.; Voets, T. Nicotine activates the chemosensory cation channel TRPA1. Nat. Neurosci., 2009, 12, 1293.
174. Macpherson, L.J.; Xiao, B.; Kwan, K.Y.; Petrus, M.J.; Dubin, A.E.; Hwang, S.; Cravatt, B.; Corey, D.P.; Patapoutian, A. An ion channel essential for sensing chemical damage. J. Neurosci., 2007, 27, 11412. (Pubitemid 47621302)
175. Taylor-Clark, T.E.; Undem, B.J.; Macglashan, D.W. Jr; Ghatta, S.; Carr, M.J.; McAlexander, M.A. Prostaglandin-induced activation of nociceptive neurons via direct interaction with transient receptor potential A1 (TRPA1). Mol. Pharmacol., 2008, 73, 274.
176. Trevisani, M.; Siemens, J.; Materazzi, S.; Bautista, D.M.; Nassini, R.; Campi, B.; Imamachi, N.; Andrè, E.; Patacchini, R.; Cottrell, G.S.; Gatti, R.; Basbaum, A.I.; Bunnett, N.W.; Julius, D; Geppetti, P. 4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1. Proc. Natl. Acad. Sci. USA, 2007, 104, 13519. (Pubitemid 47293977)
177. Hinman, A.; Chuang, H.H.; Bautista, D.M.; Julius, D. TRP channel activation by reversible covalent modification. Proc. Natl. Acad. Sci. USA, 2006, 103, 19564. (Pubitemid 46026070)
178. Taylor-Clark, T.E.; Ghatta, S.; Bettner, W.; Undem, B.J. Nitrooleic acid, an endogenous product of nitrative stress, activates nociceptive sensory nerves via the direct activation of TRPA1. Mol. Pharmacol., 2009, 75, 820.
179. Doerner, J.F.; Gisselmann, G.; Hatt, H.; Wetzel, C.H. Transient receptor potential channel A1 is directly gated by calcium ions. J. Biol. Chem., 2007, 282, 13180.
180. 2+. Nat. Neurosci., 2007, 10, 277.
181. Dai, Y.; Wang, S.; Tominaga, M.; Yamamoto, S.; Fukuoka, T.; Higashi, T.; Kobayashi, K.; Obata, K.; Yamanaka, H.; Noguchi, K. Sensitization of TRPA1 by PAR2 contributer to the sensation of inflammatory pain. J. Clin. Invest., 2007, 117, 1979. (Pubitemid 47036332)
182. Frederick, J.; Buck, M.E.; Matson, D.J.; Cortright, D.N. Increased TRPA1, TRPM8, and TRPV2 expression in dorsal root ganglia by nerve injury. Biochem. Biophys. Res. Commun., 2007, 358, 1058.
183. Ruparel, N.B.; Patwardhan, A.M.; Akopian, A.N.; Hargreaves, K.M. Homologous and heterologous desensitization of capsaicin and mustard oil responses utilize different cellular pathways in nociceptors. Pain, 2008, 135, 271.
184. Akopian, A.N.; Ruparel, N.B.; Patwardhan, A.; Hargreaves, K.M. Cannabinoids desensitize capsaicin and mustard oil responses in sensory neurons via TRPA1 activation. J. Neurosci., 2008, 28, 1064.
185. Akopian, A.N.; Ruparel, N.B.; Jeske, N.A.; Patwardhan, A.; Hargreaves, K.M. Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia. Trends Pharmacol. Sci., 2009, 30, 79.
186. De Petrocellis, L.; Vellani, V.; Schiano-Moriello, A.; Marini, P.; Magherini, P.C.; Orlando, P.; Di Marzo, V. Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8. J. Pharmacol. Exp. Ther., 2008, 325, 1007. (Pubitemid 351724325)
187. McKemy, D.D.; Neuhausser, W.M.; Julius, D. Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature, 2002, 416, 52. (Pubitemid 34215395)
188. Peier, A.M.; Moqrich, A.; Hergarden, A.C.; Reeve, A.J.; Andersson, D.A.; Story, G.M.; Earley, T.J.; Dragoni, I.; McIntyre, P.; Bevan, S.; Patapoutian, A. A TRP channel that senses cold stimuli and menthol. Cell, 2002, 108, 705. (Pubitemid 34241429)
189. Tsavaler, L.; Shapero, M.H.; Morkowski, S.; Laus, R. Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins. Cancer Res., 2001, 61, 3760. (Pubitemid 32694990)
190. Nealen, M.L.; Gold, M.S.; Thut, P.D.; Caterina, M.J. TRPM8 mRNA is expressed in a subset of cold-responsive trigeminal neurons from rat. J. Neurophysiol., 2003, 90, 515.
191. Xing, H.; Ling, J.; Chen, M.; Gu, J.G. Chemical and cold sensitivity of two distinct populations of TRPM8-expressing somatosensory neurons. J Neurophysiol., 2006, 95, 1221.
192. Proudfoot, C.J.; Garry, E.M.; Cottrell, D.F.; Rosie, R.; Anderson, H.; Robertson, D.C.; Fleetwood-Walker, S.M.; Mitchell, R. Analgesia mediated by the TRPM8 cold receptor in chronic neuropathic pain. Curr. Biol., 2006, 16, 1591. (Pubitemid 44233290)
193. Bautista, D.M.; Siemens, J.; Glazer, J.M.; Tsuruda, P.R.; Basbaum, A.I.; Stucky, C.L.; Jordt, S.E.; Julius, D. The menthol receptor TRPM8 is the principal detector of environmental cold. Nature, 2007, 448, 204. (Pubitemid 47067367)
194. Colburn, R.W.; Lubin, M.L.; Stone, D.J. Jr; Wang, Y.; Lawrence, D.; D'Andrea, M.R.; Brandt, M.R.; Liu, Y.; Flores, C.M.; Qin, N. Attenuated cold sensitivity in TRPM8 null mice. Neuron, 2007, 54, 379. (Pubitemid 46671410)
195. Dhaka, A.; Murray, A.N.; Mathur, J. Earley, T.J.; Petrus, M.J.; Patapoutian, A. TRPM8 is required for cold sensation in mice. Neuron, 2007, 54, 371. (Pubitemid 46659806)
196. Xing, H.; Chen, M.; Ling, J.; Tan, W.; Gu, J.G. TRPM8 mechanism of cold allodynia after chronic nerve injury. J. Neurosci., 2007, 27, 13680.
197. Eid, S,R,; Cortright, D,N. Transient receptor potential channels on sensory nerves. Handb. Exp. Pharmacol., 2009, 194, 261.
198. Jordt, S.E.; McKemy, D.D.; Julius, D. Lessons from peppers and peppermint: the molecular logic of thermosensation. Curr. Opin. Neurobiol., 2003, 13, 487. (Pubitemid 37088240)
199. Voets, T.; Droogmans, G.; Wissenbach, U.; Janssens, A.; Flockerzi, V.; Nilius, B. The principle of temperature-dependent gating in cold- and heat-sensitive TRP channels. Nature, 2004, 430, 748. (Pubitemid 39071340)
200. Behrendt, H.J.; Germann, T.; Gillen, C.; Hatt, H.; Jostock, R. Characterization of the mouse cold-menthol receptor TRPM8 and vanilloid receptor type-1 VR1 using a fluorometric imaging plate reader (FLIPR) assay. Br. J. Pharmacol., 2004, 141, 737. (Pubitemid 38453266)
201. Chuang, H.H.; Neuhausser, W.M.; Julius, D. The super-cooling agent icilin reveals a mechanism of coincidence detection by a temperature-sensitive TRP channel. Neuron, 2004, 43, 859. (Pubitemid 39215016)
202. Bödding, M.; Wissenbach, U.; Flockerzi, V. Characterisation of TRPM8 as a pharmacophore receptor. Cell Calcium, 2007, 42, 618.
203. Premkumar, L.S.; Raisinghani, M.; Pingle, S.C.; Long, C.; Pimentel, F. Downregulation of transient receptor potential melastatin 8 by protein kinase C-mediated dephosphorylation. J. Neurosci., 2005, 25, 11322. (Pubitemid 43083706)
204. De Petrocellis, L.; Starowicz, K.; Schiano Moriello, A.; Vivese, M.; Orlando, P.; Di Marzo, V. Regulation of transient receptor potential channels of melastatin type 8 (TRPM8): effect of cAMP, cannabinoid CB(1) receptors and endovanilloids. Exp. Cell Res., 2007, 313, 1911. (Pubitemid 46661844)
205. Liu, B.; Qin, F. Functional control of cold- and menthol-sensitive TRPM8 ion channels by phosphatidylinositol 4,5-bisphosphate. J. Neurosci., 2005, 25, 1674. (Pubitemid 40279272)
206. Rohács, T.; Lopes, C.M.; Michailidis, I.; Logothetis, D.E. PI(4,5)P2 regulates the activation and desensitization of TRPM8 channels through the TRP domain. Nat. Neurosci., 2005, 8, 626. (Pubitemid 40594204)
207. Benedikt, J.; Teisinger, J.; Vyklicky, L.; Vlachova, V. Ethanol inhibits cold-menthol receptor TRPM8 by modulating its interaction with membrane phosphatidylinositol 4,5-bisphosphate. J. Neurochem., 2007, 100, 211. (Pubitemid 46085850)
208. Andersson, D.A.; Nash, M.; Bevan, S. Modulation of the cold-activated channel TRPM8 by lysophospholipids and polyunsaturated fatty acids. J. Neurosci., 2007, 27, 3347. (Pubitemid 46474120)
209. Weil, A.; Moore, S.E.; Waite, N.J.; Randall, A.; Gunthorpe, M.J. Conservation of functional and pharmacological properties in the distantly related temperature sensors TRPV1 and TRPM8. Mol. Pharmacol., 2005, 68, 518.
210. Lashinger, E.S.; Steiginga, M.S.; Hieble, J.P.; Leon, L.A.; Gardner, S.D.; Nagilla, R.; Davenport, E.A.; Hoffman, B.E.; Laping, N.J.; Su, X. AMTB, a TRPM8 channel blocker: evidence in rats for activity in overactive bladder and painful bladder syndrome. Am. J. Physiol. Renal Physiol., 2008, 295, F803.
211. Alexander, S.P.; Kendall, D.A. The complications of promiscuity: endocannabinoid action and metabolism. Br. J. Pharmacol., 2007, 152, 602.
212. Izzo, A.A.; Borrelli, F.; Capasso, R., Di Marzo, V.; Mechoulam, R. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol. Sci., 2009, 30, 515.